Straight to content

Protection of clinical trial subjects in countries outside the EU

Posted in category:
Publication
Published on:

In this briefing paper, Wemos and SOMO call upon the European Parliament, the European Commission and the European Medicines Agency to take measures at the following three levels: 1) Vigorously pursue the integration of ethical principles into EMA procedures, 2) Increase transparency in clinical trials outside the EU and 3) Strengthen capacity in low and middle income countries.

Do you need more information?

Posted in category:
Publication
Published on:

Related news

Don't want to miss anything?

Sign up for our newsletter and always stay up to date on information and analysis on corporate power issues.